✦ LIBER ✦

Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study

✍ Scribed by Donna Glover; Alan Lipton; Alan Keller; Antonius A. Miller; Scott Browning; Robert J. Fram; Sebastian George; Kenneth Zelenakas; Richard S. Macerata; John J. Seaman

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 669 KB
Volume: 74
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19941201)74:11<2949::aid-cncr2820741110>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Simulated bone metastases: A case study

Simulated bone metastases: A case study of two patients with breast cancer

✍ Ainslie, Jill ;Hicks, Rodney ;Drummond, Roslyn ;Blakey, David ;McKenzie, Michell 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

Assessment of response of bone metastase

Assessment of response of bone metastases to systemic treatment in patients with breast cancer

✍ R. C. Coombes; P. Dady; C. Parsons; V. R. McCready; H. T. Ford; J.- C. Gazet; T. 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB 👁 2 views

Zoledronic acid is superior to pamidrona

Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion

✍ Lee S. Rosen; David H. Gordon; William Dugan Jr.; Pierre Major; Peter D. Eisenbe 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract ## BACKGROUND Treatment with zoledronic acid (Zol) was compared with a dose of 90 mg of pamidronate (Pam) in breast carcinoma (BC) patients with at least 1 osteolytic lesion based on data from a Phase III, randomized trial. ## METHODS Overall, 1130 patients with breast carcinoma who

A phase 2 trial exploring the effects of

A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D3 in breast cancer patients with bone metastases

✍ Eitan Amir; Christine E. Simmons; Orit C. Freedman; George Dranitsaris; David E. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

A phase 2 trial of whole-brain radiother

A phase 2 trial of whole-brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancer

✍ Philippe A. Cassier; Isabelle Ray-Coquard; Marie-Pierre Sunyach; Laurence Lancry 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 2 views

A randomized study of 2 dose levels of i

A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome

✍ Stefan Faderl; Guillermo Garcia-Manero; Elias Jabbour; Farhad Ravandi; Gautam Bo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 1 views

## Abstract ## BACKGROUND: Clofarabine is a nucleoside analog with activity in myeloid malignancies. Experience in myelodysplastic syndrome (MDS) is limited. ## METHODS: The goal of this study was to evaluate the activity and safety of 2 different doses (15 mg/m^2^ vs 30 mg/m^2^ daily × 5 days)